NCT03254732 2022-04-27Study ADI-PEG 20 Plus Pembrolizumab in Advanced Solid CancersPolaris GroupPhase 1 Terminated33 enrolled
NCT00337376 2014-01-14A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid CancersYale UniversityPhase 1 Terminated23 enrolled